What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Expense ratio components for Dividend Aristocrats ETFs include management fees and other ongoing costs that reduce net returns.
20,481 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
When a founder sells a sizable stake, investors take note. This article digs into the implications of airbnb co-found...
Vitalik Buterin reiterates Ethereum’s neutrality, separating personal views from the protocol. The stance arrives as ...
When a small-cap tech company reports results that miss expectations, the stock often takes a hit. This piece dives i...
Winter is signaling a shift in the housing market. Demand is creeping back as buyers expect holiday discounts, while ...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
Bitcoin steadies near $69,000 as oil spikes on Middle East tensions, marking a notable stress test for crypto's store...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
SWIFT is moving its blockchain-based cross-border settlement from pilot to production-scale, with a mid-2026 MVP and ...
Learn how xometry (xmtr) 2026 earnings shape the investment case. We break down the numbers, strategy, and risks, wit...
When doximity stock plunged today, the market focused on earnings quality and future profitability. This article brea...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...